Staphylococcus aureus Rosenbach (ATCC® BAA-1683)

Strain Designations: HFH-30364  /  Type Strain: no  /  Biosafety Level: 2

Strain Designations HFH-30364
Emerging infectious disease research
Drug discovery
Enteric Research
Human abscess; Henry Ford Hospital, 2004
Biosafety Level 2

Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

Product Format freeze-dried
Storage Conditions Frozen: -80°C or colder
Freeze-Dried: 2°C to 8°C
Live Culture: See Propagation Section
Preceptrol® no
Genotype pvl positive
Type Strain no
Antibiotic Resistance
Methicillin resistant
Comments MRSA
SCCmec: Type IV a
PFGE type: USA400
spa type Ridom: t125
spa type Kreiswirth: UJJJJFE
pvl gene amplification: Positive
Clonal complex: CC1
Sequence type: ST1
Agr type: III

Phenotypic and genotypic information for ATCC MRSA strains, such as SCCmec, PFGE, or spa typing, is provided for informational purposes only. This information was compiled from testing performed by one or more sources, including ATCC, strain depositor, published data, or contracted research.
Medium ATCC® Medium 18: Trypticase Soy Agar/Broth
Growth Conditions
Temperature: 37°C
Atmosphere: Aerobic
Genotype pvl positive
Name of Depositor M Zervos; Henry Ford Hospital, Detroit, MI
Human abscess; Henry Ford Hospital, 2004
Year of Origin 2004

Davis, SL, et al. Epidemiology and outcomes of community-associated methicillin-resistant Staphylococcus aureus infection. J. Clin. Microbiol. 45(6): 1705-1711, 2007. PubMed: 17392441

Monecke S, et al. A field guide to pandemic, epidemic and sporadic clones of methicillin-resistant Staphylococcus aureus. PLoS One 6(4): e17936, 2011. PubMed: 21494333